---
figid: PMC6334365__CRP2019-9846312.004
figtitle: IL-6–JAK/STAT–SOCS3 signalling pathway
organisms:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Sus scrofa
- Homo sapiens
organisms_ner:
- Mus musculus
- Rattus norvegicus
- Bos taurus
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC6334365
filename: CRP2019-9846312.004.jpg
figlink: /pmc/articles/PMC6334365/figure/fig4/
number: F4
caption: The IL-6–JAK/STAT–SOCS3 signalling pathway. The principal signalling pathway
  triggered by IL-6 is the JAK/STAT pathway (orange). JAK phosphorylates gp130 leading
  to phosphorylation and dimerisation of STAT, which translocates to the nucleus to
  induce expression of prosurvival and proinflammatory genes. It also induces expression
  of SOCS3 as a negative feedback loop to switch off the signalling pathway (green).
  SOCS3 forms part of the E3 ubiquitin ligase complex to ubiquitinate JAK, leading
  to proteasomal degradation and termination of the signalling cascade. JAK can also
  act independently of STAT to trigger additional mitogenic and growth-promoting effects
  via the PI3K/Akt and ERK1/2 pathways (blue). Sites of action of specific therapeutic
  inhibitors are indicated in red boxes.
papertitle: Therapeutic Targeting of the Proinflammatory IL-6-JAK/STAT Signalling
  Pathways Responsible for Vascular Restenosis in Type 2 Diabetes Mellitus.
reftext: Florah Tshepo Moshapa, et al. Cardiol Res Pract. 2019;2019:9846312.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9523445
figid_alias: PMC6334365__F4
figtype: Figure
redirect_from: /figures/PMC6334365__F4
ndex: cceb6f17-def0-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6334365__CRP2019-9846312.004.html
  '@type': Dataset
  description: The IL-6–JAK/STAT–SOCS3 signalling pathway. The principal signalling
    pathway triggered by IL-6 is the JAK/STAT pathway (orange). JAK phosphorylates
    gp130 leading to phosphorylation and dimerisation of STAT, which translocates
    to the nucleus to induce expression of prosurvival and proinflammatory genes.
    It also induces expression of SOCS3 as a negative feedback loop to switch off
    the signalling pathway (green). SOCS3 forms part of the E3 ubiquitin ligase complex
    to ubiquitinate JAK, leading to proteasomal degradation and termination of the
    signalling cascade. JAK can also act independently of STAT to trigger additional
    mitogenic and growth-promoting effects via the PI3K/Akt and ERK1/2 pathways (blue).
    Sites of action of specific therapeutic inhibitors are indicated in red boxes.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Il6
  - ras
  - Hras
  - Kras
  - Rem1
  - Ptpn11
  - Socs3
  - Pik3r1
  - Mapk3
  - Mapk1
  - Akt1
  - Il11ra1
  - Il6st
  - Lrpprc
  - Pck1
  - Pik3cg
  - IL6
  - PTPN11
  - SOCS3
  - PIK3CB
  - MAPK3
  - MAPK1
  - AKT1
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KRAS
  - HRAS
  - NRAS
  - MTG1
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - PIK3CA
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT2
  - AKT3
  - IL6ST
  - NM
  - LRPPRC
  - hop
  - bsk
  - Ras64B
  - Ras85D
  - csw
  - grb
  - Stat92E
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - rl
  - Akt
  - Neurl4
  - Ruxolitinib
  - GDP
  - OPB-31121
  - Cancer
---
